Financials

  • Market Capitalization 6.44 B
  • Employee 258
  • Founded 2014
  • CEO N/A
  • Website www.cogentbio.com
  • Headquarter Delaware, United States
  • FIGI BBG007DHZQR7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1138
ERAS
Erasca, Inc. - Common Stock
19.49 USD+1.78%+12.79%+8.28%+1125.79%6.82 B USD
1177
MIRM
Mirum Pharmaceuticals, Inc. - common stock
99.75 USD+1.26%+2.15%-10.97%+42.24%6.48 B USD
1192
TVTX
Travere Therapeutics, Inc. - Common Stock
67.52 USD+0.60%+4.23%+20.46%+134.69%6.36 B USD
1200
LQDA
Liquidia Corporation - Common Stock
69.94 USD-1.99%-1.37%-19.44%+209.47%6.26 B USD

Frequently asked questions about Cogent Biosciences, Inc. Common Stock

What is the Cogent Biosciences, Inc. Common Stock stock price today?

The current price of Cogent Biosciences, Inc. Common Stock (COGT) is 37.09. Over the past 24 hours, the stock has changed by +1.01%. Follow the COGT chart for real-time price dynamics.

What is the stock ticker of Cogent Biosciences, Inc. Common Stock?

Cogent Biosciences, Inc. Common Stock trades under the ticker COGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cogent Biosciences, Inc. Common Stock stock going up?

COGT has changed by +3.75% over the last week, -8.80% over the last month, and +136.69% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Cogent Biosciences, Inc. Common Stock?

Cogent Biosciences, Inc. Common Stock currently has a market capitalization of 6.44 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Cogent Biosciences, Inc. Common Stock earnings last quarter?

Last quarter, Cogent Biosciences, Inc. Common Stock reported earnings of -0.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Cogent Biosciences, Inc. Common Stock revenue for the last quarter?

Cogent Biosciences, Inc. Common Stock reported quarterly revenue of 1 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Cogent Biosciences, Inc. Common Stock net income for the last quarter?

Cogent Biosciences, Inc. Common Stock reported net income of -96.41 M for the last quarter. The previous quarter showed -97.35 M, which means net income changed by +0.97%.

How many employees does Cogent Biosciences, Inc. Common Stock have?

As of the latest available data, Cogent Biosciences, Inc. Common Stock has 258 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cogent Biosciences, Inc. Common Stock EBITDA?

Cogent Biosciences, Inc. Common Stock EBITDA is -103.31 M, and its EBITDA margin is -10.33 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cogent Biosciences, Inc. Common Stock stock?

You can buy Cogent Biosciences, Inc. Common Stock (COGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cogent Biosciences, Inc. Common Stock stock?

Investing in Cogent Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COGT chart and related analysis on metatrader.com as part of your research.

News